These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22757647)

  • 1. Recessive dystrophic epidermolysis bullosa: the origin of the c.6527insC mutation in the Spanish population.
    Sanchez-Jimeno C; Cuadrado-Corrales N; Aller E; García M; Escámez MJ; Illera N; Trujillo-Tiebas MJ; Ayuso C; Millán JM; Del Río M
    Br J Dermatol; 2013 Jan; 168(1):226-9. PubMed ID: 22757647
    [No Abstract]   [Full Text] [Related]  

  • 2. A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families.
    Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Escámez MJ; Illera N; Hernández-Martín A; Trujillo-Tiebas MJ; Ayuso C; Del Rio M
    BMC Med Genet; 2010 Sep; 11():139. PubMed ID: 20920254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation.
    Escámez MJ; García M; Cuadrado-Corrales N; Llames SG; Charlesworth A; De Luca N; Illera N; Sánchez-Jimeno C; Holguín A; Duarte B; Trujillo-Tiebas MJ; Vicario JL; Santiago JL; Hernández-Martín A; Torrelo A; Castiglia D; Ayuso C; Larcher F; Jorcano JL; Meana A; Meneguzzi G; Zambruno G; Del Rio M
    Br J Dermatol; 2010 Jul; 163(1):155-61. PubMed ID: 20184583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A COL7A1 variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa.
    Schwieger-Briel A; Weibel L; Chmel N; Leppert J; Kernland-Lang K; Grüninger G; Has C
    Br J Dermatol; 2015 Nov; 173(5):1308-11. PubMed ID: 26076072
    [No Abstract]   [Full Text] [Related]  

  • 5. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
    von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
    Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recessive dystrophic epidermolysis bullosa: identification of a novel COL7A1 mutation of D44N.
    Makino E; Nakano H; Sawamura D; Fujimoto W
    J Dermatol Sci; 2012 Nov; 68(2):109-12. PubMed ID: 22854212
    [No Abstract]   [Full Text] [Related]  

  • 7. Dystrophic epidermolysis bullosa with one dominant and one recessive mutation of the COL7A1 gene in a child with deafness.
    Weinel S; Lucky AW; Uitto J; Pfendner EG; Choo D
    Pediatr Dermatol; 2008; 25(2):210-4. PubMed ID: 18429782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel and recurrent COL7A1 mutations in Chilean patients with dystrophic epidermolysis bullosa.
    Rodríguez FA; Gana MJ; Yubero MJ; Zillmann G; Krämer SM; Catalán J; Rubio-Astudillo J; González S; Liu L; Ozoemena L; Mellerio JE; McGrath JA; Palisson F; Conget P
    J Dermatol Sci; 2012 Feb; 65(2):149-52. PubMed ID: 22209565
    [No Abstract]   [Full Text] [Related]  

  • 9. Skipped exon in COL7A1 determines the clinical phenotypes of dystrophic epidermolysis bullosa.
    Toyonaga E; Nishie W; Komine M; Murata S; Shinkuma S; Natsuga K; Nakamura H; Ohtsuki M; Shimizu H
    Br J Dermatol; 2015 Apr; 172(4):1141-4. PubMed ID: 25196227
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy for recessive dystrophic epidermolysis bullosa.
    Titeux M; Pendaries V; Hovnanian A
    Dermatol Clin; 2010 Apr; 28(2):361-6, xii. PubMed ID: 20447504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygosity of the novel -186C>T mutation in the COL7A1 promoter and the recurrent c.497insA mutation leads to generalized dystrophic epidermolysis bullosa.
    Ritelli M; Chiarelli N; Quinzani S; Dordoni C; Venturini M; Calzavara-Pinton P; Colombi M
    Br J Dermatol; 2013 Apr; 168(4):904-6. PubMed ID: 23013315
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel human pathological mutations. Gene symbol: COL7A1. Disease: Epidermolysis bullosa dystrophica.
    García M; Escamez MJ; Cuadrado-Corrales N; Illera N; Sánchez Jimeno C; Vélez C; Trujillo-Tiebas MJ; Ayuso C; Del Río M
    Hum Genet; 2010 Jan; 127(1):120-1. PubMed ID: 20108398
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel deletion mutation (c.3717del5) in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.
    Lee SH; Kim SE; Noh EB; Oh SW; Kim SC
    J Dermatol; 2013 Jan; 40(1):59-61. PubMed ID: 22974128
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of recessive dystrophic epidermolysis bullosa caused by compound heterozygous mutations in the COL7A1 gene.
    Suzuki S; Shimomura Y; Yamamoto Y; Kariya N; Shibuya M; Ito M; Fujiwara H
    Br J Dermatol; 2006 Oct; 155(4):838-40. PubMed ID: 16965439
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel human pathological mutations. Gene symbol: COL7A1. Disease: Epidermolysis bullosa dystrophica.
    García M; Escamez MJ; Cuadrado-Corrales N; Sánchez-Jimeno C; Illera N; López-Martínez MA; Trujillo-Tiebas MJ; Ayuso C; Del Río M
    Hum Genet; 2010 Jan; 127(1):116-7. PubMed ID: 20108428
    [No Abstract]   [Full Text] [Related]  

  • 16. First report of COL7A1 mutations in two patients with recessive dystrophic epidermolysis bullosa from Peru.
    Saeidian AH; Youssefian L; Rosales-Solis GM; Vahidnezhad H; Atanasova VS; Uitto J; South AP; Salas-Alanis JC
    Clin Exp Dermatol; 2018 Aug; 43(6):719-722. PubMed ID: 29427316
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural gene therapy in dystrophic epidermolysis bullosa.
    van den Akker PC; Nijenhuis M; Meijer G; Hofstra RM; Jonkman MF; Pasmooij AM
    Arch Dermatol; 2012 Feb; 148(2):213-6. PubMed ID: 22004882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked ichthyosis along with recessive dystrophic epidermolysis bullosa in the same patient.
    Hernández-Martín A; Cuadrado-Corrales N; Ciria-Abad S; Arias-Palomo D; Mascaró-Galy JM; Escámez MJ; García M; Del Río M; Torrelo A; González-Sarmiento R
    Dermatology; 2010; 221(2):113-6. PubMed ID: 20523032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Japanese family with dominant pretibial dystrophic epidermolysis bullosa: Identification of a new glycine substitution in the triple-helical collagenous domain of type VII collagen.
    Hamada T; Fukuda S; Ishii N; Abe T; Nagata K; Koro O; Hatano Y; Nakano H; Sawamura D; Hashimoto T
    J Dermatol Sci; 2009 Jun; 54(3):212-4. PubMed ID: 19269793
    [No Abstract]   [Full Text] [Related]  

  • 20. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen.
    van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF
    J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.